Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2011

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
Eltrombopag may improve the cell collection available for Autologous Stem Cell Transplant(ASCT). The overall goal is to determine if adding Eltrombopag to the standard ASCT will increase the number of blood cells collected and reduce the number of times blood needs to be collected. This study will also determine the highest dose of Eltrombopag that can be used without causing serious side effects.
Epistemonikos ID: 760b8d52f094dd97f8466fc61f8f3a27e7edcabe
First added on: May 06, 2024